Alpha 2.0
Login Register
» Authors » Anne Benard-Slagter

Anne Benard-Slagter

Explore the profile of Anne Benard-Slagter including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 40
Followers 0
Related Specialties
Oncology
Pathology
Molecular Biology
Top 10 Co-Authors
Suvi Savola
Andras Matolcsy
Bela Kajtar
Balint Egyed
Gabor Kovacs
Karel de Groot
Csaba Bodor
Donat Alpar
Iren Haltrich
Szilvia Krizsan
Published In
Mod Pathol
J Mol Diagn
Breast Cancer Res
Front Oncol
Br J Cancer
Affiliations
Soon will be listed here.
Recent Articles
1.
Molecular Profiling Reveals Novel Gene Fusions and Genetic Markers for Refined Patient Stratification in Pediatric Acute Lymphoblastic Leukemia
Peterffy B, Krizsan S, Egyed B, Bedics G, Benard-Slagter A, Palit S, et al.
Mod Pathol . 2025 Feb; 38(6):100741. PMID: 40010436
Risk-adapted treatment protocols conferred remarkable improvement in the survival rates of pediatric acute lymphoblastic leukemia/lymphoma (ALL/LBL). Nevertheless, clinical management is still challenging in certain molecular subgroups and in the presence...
2.
PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia
Bedics G, Egyed B, Kotmayer L, Benard-Slagter A, de Groot K, Beko A, et al.
Br J Cancer . 2023 Jun; 129(3):455-465. PMID: 37340093
Background: Recurrent genetic lesions provide basis for risk assessment in pediatric acute lymphoblastic leukemia (ALL). However, current prognostic classifiers rely on a limited number of predefined sets of alterations. Methods:...
3.
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer
Lips E, Benard-Slagter A, Opdam M, Scheerman C, Wesseling J, Hogervorst F, et al.
Breast Cancer Res . 2020 Jul; 22(1):79. PMID: 32711554
Background: We previously showed that BRCA-like profiles can be used to preselect individuals with the highest risk of carrying BRCA mutations but could also indicate which patients would benefit from...
4.
Comprehensive profiling of disease-relevant copy number aberrations for advanced clinical diagnostics of pediatric acute lymphoblastic leukemia
Kiss R, Gango A, Benard-Slagter A, Egyed B, Haltrich I, Hegyi L, et al.
Mod Pathol . 2019 Dec; 33(5):812-824. PMID: 31857684
Acute lymphoblastic leukemia is the most common pediatric cancer characterized by a heterogeneous genomic landscape with copy number aberrations occurring at various stages of pathogenesis, disease progression, and treatment resistance....
5.
Rapid Identification of Key Copy Number Alterations in B- and T-Cell Acute Lymphoblastic Leukemia by Digital Multiplex Ligation-Dependent Probe Amplification
Thakral D, Kaur G, Gupta R, Benard-Slagter A, Savola S, Kumar I, et al.
Front Oncol . 2019 Oct; 9:871. PMID: 31572674
Recurrent clonal genetic alterations are the hallmark of Acute Lymphoblastic Leukemia (ALL) and govern the risk stratification, response to treatment and clinical outcome. In this retrospective study conducted on ALL...
6.
Digital Multiplex Ligation-Dependent Probe Amplification for Detection of Key Copy Number Alterations in T- and B-Cell Lymphoblastic Leukemia
Benard-Slagter A, Zondervan I, de Groot K, Ghazavi F, Sarhadi V, Van Vlierberghe P, et al.
J Mol Diagn . 2017 Jul; 19(5):659-672. PMID: 28736295
Recurrent and clonal genetic alterations are characteristic of different subtypes of T- and B-cell lymphoblastic leukemia (ALL), and several subtypes are strong independent predictors of clinical outcome. A next-generation sequencing-based...